Warburg Pincus has made one of the largest investment in HRTech in LatAm by leading a $100m series B round in Brazilian human resources startup Solides. Solides provides human resources management software and corporate education
Venture capital firm Thrive Capital has closed Thrive VIII on $3bn, with $500m for early-stage investments and $2.5bn for late-stage investments. The post Jared Kushner’s brother Joshua closes eighth Thrive Capital fund on $3bn first
Consumer-focused early-stage investment house Forerunner Ventures has pulled in $1bn for its sixth flagship fund, twice the amount it collected for its 2020 predecessor vehicle. The post Forerunner Ventures raises $1bn for Fund VI, double
Venture capital veteran Sequoia Capital is creating a dedicated cryptocurrency fund as one of a trio of new vehicles which could raise more than $5bn between them. The post Sequoia Capital launches crypto vehicle amid
AlbionVC, a venture capital firm focused on health technology, has hired Molly Gilmartin from McKinsey, where she focused on healthcare systems and technology for two years.
Real estate tech-focused venture capital house Fifth Wall has expanded its investment outreach to Europe with the €140m final close for its latest real estate technology fund. The post Fifth Wall expands its proptech investing to Europe
FinTech Flutterwave has become Africa's most valuable fintech after a new wave of VC funding saw become worth more than $3bn. The post Flutterwave becomes Africa’s most valuable startup at $3bn thanks to new VC
Venture capital firm HV Capital has announced the formation of a EUR 430m continuation vehicle, HV COCO Growth, to house the remaining portfolio companies of its funds from 2010-2015.
Private equity major Apax Partners is already eyeing up to $13bn for its latest flagship fundraise, just a year after closing its $11bn Fund X vehicle. The post Apax Partners eyes $13bn Fund XI raise
UCB Ventures and Ysios Capital have led a EUR 50m Series A for SpliceBio, a Spanish biotech company working on protein splicing for gene therapies.
Asia-Pacific dealmaking across private equity, venture capital and M&A nosedived in January as the Omicron variant of Covid-19 surged through the region. The post Omicron variant spread sees Asia-Pacific deal activity slump first appeared on
